Streetbeat News

Stock Prices

KBR

KBR has reaffirmed its FY23 guidance with expected revenue between $6.9B-$7.1B, which is in line with the consensus of $7.07B. The company also expects its adjusted EPS to be between $2.76-$2.96, close to the consensus of $2.91.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 10:17 am

FCFS

FirstCash's Board of Directors has approved a $200 million share repurchase authorization. This move is expected to return value to shareholders and potentially boost the company's stock price.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 10:11 am

MDC

M.D.C. Holdings, Inc. (NYSE:MDC) has projected its Q3 home deliveries to be between 1,850 and 2,000 units. The company also expects the average selling price for these units to be approximately $555,000.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 10:11 am

LKQ

LKQ Corporation has revised its FY23 adjusted EPS outlook from $3.90 - $4.20 to $3.90 - $4.10, which is slightly below the estimated $4.02.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 10:04 am

LKQ

LKQ Corporation reported Q2 adjusted earnings of $1.09 per share, beating the analyst consensus estimate of $1.07 by 1.87%. However, the company's quarterly sales of $3.44 billion missed the analyst consensus estimate of $3.46 billion by 0.58%. The sales figure represents a 2.96% increase over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 10:01 am

PPBI

Pacific Premier Bancorp (NASDAQ:PPBI) reported Q2 earnings of $0.60 per share, beating the analyst consensus estimate of $0.58 by 3.45%. However, this is a 17.81% decrease from the same period last year. The company also reported quarterly sales of $180.63 million, surpassing the analyst consensus estimate of $161.22 million by 12.04%, but this is a 7.35% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 10:01 am

WST

West Pharmaceutical Servs (NYSE:WST) reported Q2 earnings of $2.11 per share, beating the analyst consensus estimate of $1.93 by 9.33%. However, this is a 14.57% decrease from the same period last year. The company's quarterly sales of $753.80 million missed the analyst consensus estimate of $756.53 million by 0.36%, marking a 2.27% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 10:01 am

EYE

Wells Fargo analyst Zachary Fadem has downgraded National Vision Holdings (NASDAQ:EYE) from Overweight to Equal-Weight.

Portfolio Pulse from richadhand@benzinga.com

July 27, 2023 | 9:57 am

AMZN

MSFT

SNAP

The S&P 500 closed slightly lower while the Dow Jones recorded gains for the 13th straight session. The Fed raised its benchmark overnight interest rate by 25 basis points. Microsoft Corporation shares fell 3.8% after issuing guidance below estimates. Snap Inc. shares fell over 14% after reporting Q3 results. The Nasdaq 100 fell 0.40% amid losses in shares of Microsoft and Amazon.com. The CBOE Volatility Index fell 5.8%.

Portfolio Pulse from Lisa Levin

July 27, 2023 | 9:55 am

EL

Jefferies analyst Ashley Helgans has downgraded Estee Lauder Cos (NYSE:EL) from Buy to Hold and lowered the price target from $270 to $190.

Portfolio Pulse from richadhand@benzinga.com

July 27, 2023 | 9:55 am